Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1057244510 | 10572445 | 10 | F | 20150120 | 20160628 | 20141110 | 20160630 | EXP | CA-ROCHE-1486999 | ROCHE | 57.54 | YR | M | Y | 80.00000 | KG | 20160630 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1057244510 | 10572445 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2027B19,B2038B05,B2028B10,B2044B06 | 125276 | 320 | MG | INFUSION | |||||||
| 1057244510 | 10572445 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2027B19,B2038B05,B2028B10,B2044B06 | 125276 | 332 | MG | INFUSION | |||||||
| 1057244510 | 10572445 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2027B19,B2038B05,B2028B10,B2044B06 | 125276 | 252 | MG | INFUSION | |||||||
| 1057244510 | 10572445 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2027B19,B2038B05,B2028B10,B2044B06 | 125276 | 320 | MG | INFUSION | |||||||
| 1057244510 | 10572445 | 5 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2027B19,B2038B05,B2028B10,B2044B06 | 125276 | 324 | MG | INFUSION | |||||||
| 1057244510 | 10572445 | 6 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | DOSE INCREASED TO TO 6MG/KG 2 OR 3 MONTHS AGO | B2027B19,B2038B05,B2028B10,B2044B06 | 125276 | 400 | MG | INFUSION | ||||||
| 1057244510 | 10572445 | 7 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2027B19,B2038B05,B2028B10,B2044B06 | 125276 | 480 | MG | INFUSION | |||||||
| 1057244510 | 10572445 | 8 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2027B19,B2038B05,B2028B10,B2044B06 | 125276 | 492 | MG | INFUSION | |||||||
| 1057244510 | 10572445 | 9 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2027B19,B2038B05,B2028B10,B2044B06 | 125276 | 500 | MG | INFUSION | |||||||
| 1057244510 | 10572445 | 10 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2027B19,B2038B05,B2028B10,B2044B06 | 125276 | 507 | MG | INFUSION | |||||||
| 1057244510 | 10572445 | 11 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2027B19,B2038B05,B2028B10,B2044B06 | 125276 | 516 | MG | INFUSION | |||||||
| 1057244510 | 10572445 | 12 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 1057244510 | 10572445 | 13 | C | EPIPEN | EPINEPHRINE | 1 | Unknown | AS REQUIRED | 0 | ||||||||||
| 1057244510 | 10572445 | 14 | C | BUTRANS | BUPRENORPHINE | 1 | 0 | ||||||||||||
| 1057244510 | 10572445 | 15 | C | ASAPHEN | ASPIRIN | 1 | Unknown | EC | 0 | ||||||||||
| 1057244510 | 10572445 | 16 | C | Atorvastatin | ATORVASTATIN | 1 | 0 | ||||||||||||
| 1057244510 | 10572445 | 17 | C | QUETIAPINE. | QUETIAPINE | 1 | 0 | ||||||||||||
| 1057244510 | 10572445 | 18 | C | VITAMIN B6 | PYRIDOXINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 1057244510 | 10572445 | 19 | C | EZETROL | EZETIMIBE | 1 | 0 | ||||||||||||
| 1057244510 | 10572445 | 20 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 1057244510 | 10572445 | 21 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 1057244510 | 10572445 | 22 | C | ATROVENT | IPRATROPIUM BROMIDE | 1 | 0 | ||||||||||||
| 1057244510 | 10572445 | 23 | C | PROLIA | DENOSUMAB | 1 | 0 | ||||||||||||
| 1057244510 | 10572445 | 24 | C | NITRO SUBLINGUAL | 2 | 0 | |||||||||||||
| 1057244510 | 10572445 | 25 | C | ISONIAZID. | ISONIAZID | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1057244510 | 10572445 | 1 | Rheumatoid arthritis |
| 1057244510 | 10572445 | 25 | Tuberculosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1057244510 | 10572445 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1057244510 | 10572445 | Arthralgia | |
| 1057244510 | 10572445 | Back pain | |
| 1057244510 | 10572445 | Blood pressure increased | |
| 1057244510 | 10572445 | Infusion related reaction | |
| 1057244510 | 10572445 | Musculoskeletal stiffness | |
| 1057244510 | 10572445 | Neck pain | |
| 1057244510 | 10572445 | Oxygen saturation decreased | |
| 1057244510 | 10572445 | Pain | |
| 1057244510 | 10572445 | Pain in extremity | |
| 1057244510 | 10572445 | Pelvic pain | |
| 1057244510 | 10572445 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1057244510 | 10572445 | 1 | 20140909 | 0 | ||
| 1057244510 | 10572445 | 2 | 20141003 | 0 | ||
| 1057244510 | 10572445 | 3 | 20141104 | 0 | ||
| 1057244510 | 10572445 | 4 | 20141212 | 0 | ||
| 1057244510 | 10572445 | 5 | 20150217 | 0 | ||
| 1057244510 | 10572445 | 6 | 20150318 | 0 | ||
| 1057244510 | 10572445 | 7 | 20150512 | 0 | ||
| 1057244510 | 10572445 | 8 | 20151008 | 0 | ||
| 1057244510 | 10572445 | 9 | 20151105 | 0 | ||
| 1057244510 | 10572445 | 10 | 20151203 | 0 | ||
| 1057244510 | 10572445 | 11 | 20160404 | 0 | ||
| 1057244510 | 10572445 | 25 | 201410 | 0 |